Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Other Non-Current Assets (2016 - 2025)

Vycor Medical has reported Other Non-Current Assets over the past 16 years, most recently at $6000.0 for Q4 2025.

  • Quarterly Other Non-Current Assets changed 0.0% to $6000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $6000.0 for FY2025, 0.0% changed from the prior year.
  • Other Non-Current Assets was $6000.0 for Q4 2025 at Vycor Medical, down from $130125.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $155804.0 in Q4 2023 and troughed at $182.0 in Q1 2022.
  • The 5-year median for Other Non-Current Assets is $6000.0 (2021), against an average of $17467.9.
  • Year-over-year, Other Non-Current Assets tumbled 96.15% in 2024 and then skyrocketed 13314.95% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $6000.0 in 2021, then plummeted by 79.8% to $1212.0 in 2022, then soared by 12755.12% to $155804.0 in 2023, then tumbled by 96.15% to $6000.0 in 2024, then changed by 0.0% to $6000.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Other Non-Current Assets are $6000.0 (Q4 2025), $130125.0 (Q3 2025), and $6000.0 (Q2 2025).